Leishmaniasis: effect of enalaprilat on the production of (ON) and cytokines in vitro
DOI:
https://doi.org/10.33448/rsd-v10i3.12949Keywords:
Leishmaniasis; Enalaprilate; Immunomodulation; Cytokines.Abstract
Leishmaniasis is neglected diseases; the drugs used have significant toxic effects that compromise patient compliance, and increased loss of efficacy due to increased resistant infectious strains. Assays on Swiss mice infected with Leishmania brasiliensis and treated with Angiotensin-Suppressing Enzyme (ACE) inhibitors showed that, in addition to the classical effects on the cardiovascular system, some of these inhibitors had effects on nonhemodynamic, immunomediated functions such as cytokine production. In this study, the effect of enalaprilate on nitric oxide (NO) production and cytokines were evaluated, i.e., interleukins-10 and 12 and IFN-γ in J774 A.1 macrophages infected by Leishmania braziliensis. Enalaprilate demonstrated in vitro immunomodulatory capacity, increasing the release of NO to induce IL-12 and IFN-γ also decreasing il-10 release.
References
Al-Nasiry S., Geusens N., Hanssens M., Luyten C. & Pijnenborg R. (2007). The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Hum Reprod. May; 22(5):1304-9.
Amoa-Bosompem, M., Ohashi, M., Mosore, M.T. Agyapong, J., Tung, N.H., Kwofie, K. D. & Ohta N. (2016) In vitro anti-Leishmania activity of tetracyclic iridoids from Morinda lucida, benth. Trop Med Health. 5;44:25. doi: 10.1186/s41182-016-0026-5.
Araújo, J. L., Santos, G. T., Sousa, L. A. de, Santos, G. T., Silva, W. de F., Sousa, A. de O. & Rocha, J. A. (2020). Molecular docking of rutenum complex with epiisopyloturin and nitric oxide against nucleoside diphosphate kinase protein Leishmania. Research, Society and Development, 9(2), e59922121. https://doi.org/10.33448/rsd-v9i2.2121
Bhattacharjee, S., Gupta, G., Bhattacharya, P., Mukherjee, A., Mujumdar, S.B., Pal, A. & Majumdar, S. (2009). Quassins alters the immunological patterns of murine macrophages through generation of nitric oxide to exert antileishmanial activity. The Journal of antimicrobial chemotherapy, v. 63, n. 2, p. 317-24.
Brasil. Ministério da Saúde. (2010b). Doenças negligenciadas: estratégias do Ministério da Saúde Revista de Saúde Pública; 44(1):200-2.
Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde (2010a). Manual de Vigilância da Leishmaniose Tegumentar Americana, 2. ed. atual. – Brasília : Editora do Ministério da Saúde.
Castellano, L. R., Filho, D. C., Argiro, L., Dessein, H., Prata, A., Dessein, A. & Rodrigues, V. (2009). Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production. Human Immunology, New York, v. 70, n. 6, p. 383-390.
Chang, K.P. (1980) Human cutaneous Leishmania in a mouse macrophage line: propagation and isolation of intracellular parasites. Science, v. 209, p. 1240-1242.
Conti, P., Kempuraj, D., Kandere, K., Di Gioacchino, M., Barbacane, R.C., Castellani, M.L. & Theoharides, T.C. (2003). IL-10, an inflammatory/inhibitory cytokine, but not always. Immunology letters, v. 86(2), p. 123-9.
Das, B. B., Sen, N., Dasgupta, S. B., Ganguly, A., Das, R. & Majumder, H.K. (2006) Topoisomerase research of kinetoplastid parasite Leishmania, with special reference to development of therapeutics. The Indian journal of medical research, v. 123 (3), p. 221-32.
De Albuquerque, D. A., Saxena V., Adams, D.E., Boivin, G. P., Brunner, H.I., Witte, D. P. & Singh, R.R. ( 2004) An ACE inhibitor reduces Th2 cytokines and TGF-β1 and TGF-β2 isoforms in murine lupus nephritis. Kidney Int 65:846-59.
De Souza Carmo, E.V., Katz, S. & Barbiéri, C. L. (2010). Neutrophils reduce the parasite burden in Leishmania (Leishmania) amazonensis-infected macrophages. 3;5(11):e13815. doi: 10.1371/journal pone.0013815.
Ding, A. H., Nathan, C. F. & Stuehr, D. J. (1988) Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol. 1;141(7):2407-12.
Dudeck, A., Suender, C. A., Kostka, S. L., von Stebut, E. & Maurer, M. (2011). Mast cells promote Th1 and Th17 responses by modulating dendritic cell maturation and function. Eur J Immunol. 41(7):1883-93. doi: 10.1002/eji.201040994.
Dutra, W. O., de Faria, D. R., Lima Machado, P. R., Guimaraes, L. H., Schriefer, A., Carvalho, E. & Gollob, J. G. (2011) Immunoregulatory and Effector Activities in Human Cutaneous and Mucosal Leishmaniasis: Understanding Mechanisms of Pathology. Drug Dev Res.;72(6):430–6.
Fournet, A., Barrios, A. A., Muñoz, V., Hocquemiller, R. & Cavé, A. (1992) Effect of natural naphthoquinones in BALB/c mice infected with Leishmania amazonensis and L. venezuelensis. Trop Med Parasitol. 43(4):219-22.
Froelich, S., Onegim, B., Kakooko, A., Siems, K., Schubert, C. & Jenett-Siems K. (2007) Plants traditionally used against malaria: phytochemical and pharmacological investigation of Momordica foetida. Rev. bras. farmacogn. vol.17 no.1.
Gannavaram, S., Bhattacharya, P., Ismail, N., Kaul, A., Singh, R. & Nakhasi, H.L. (2016) Modulation of Innate Immune Mechanisms to Enhance Leishmania Vaccine-Induced Immunity: Role of Coinhibitory Molecules. Front Immunol. 13;7:187. doi: 10.3389/fimmu.2016.00187.
Gollob, K. J., Viana, A. G. & Dutra, W. O. (2014). Immunoregulation in human American leishmaniasis: balancing pathology and protection. Parasite Immunol 36:367–76.10.1111/pim.12100.
Grutz, G. (2005) New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. Journal of leukocyte biology, v. 77(1), p. 3-15.
Hadighi, R., Mohebali, M., Boucher, P., Hajjaran, H., Khamesipour, A. & Ouellette, M. (2006). Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drugresistant Leishmania tropica parasites. PLoS Med. 3, 659-667.
Himmelrich, H., Launois, P., Maillard, I., Biedermann, T., Tacchini-Cottier, F., Locksley, R. M. & Louis, J. A. (2000). In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and suffi cient to instruct Th2 cell development resulting in progressive disease. major is necessary and suffi cient to instruct Th2 cell development resulting in progressive disease. major J Immunol 164: 4819-4825.
Kim, M. P., Zhou, M. & Wahl, L.M. (2005) Angiotensin II increases human monocyte matrix metalloproteinase-1 through the AT2 receptor and prostaglandin E2: implications for atherosclerotic plaque rupture. J Leukoc Biol; 78:195-201.
Lakshmi, V., Pandey, K., Kapil, A., Singh, N., Samant, M. & Dube, A. (2007) In vitro and in vivo leishmanicidal activity of Dysoxylum bicnectariferum and its fractions against Leishmania donovani. Phytomedicine, v. 14, p. 36-42.
Liew, F. Y. & O'donnell, C. A. (1993) Immunology of leishmaniasis. Advances in parasitology, v. 32, p. 161-259.
Malla, N. & Mahajan, R. C. (2006) Pathophysiology of visceral leishmaniasis - some recent concepts. Indian J Med Res. 123, 267-274.
McGwire, B. S. & Satoskar AR. (2014). Leishmaniasis: clinical syndromes and treatment. QJM; 107:7-14.
Muniz, A. C., Bacellar, O., Lago, E., Carvalho, A.M., Carneiro, P. P., Guimarães, L. H. & Carvalho, E. M. (2016). Immunologic Markers of Protection in Leishmania (Viannia) braziliensis Infection: A 5-Year Cohort Study. J Infect Dis. 15;214(4):570-6. doi: 10.1093/infdis/jiw196.
Okwor, I. & Uzonna, J.E. (2016). Pathways leading to interleukin-12 production and protective immunity in cutaneous leishmaniasis. Cell Immunol. pii: S0008-8749(16)30049-1. doi: 10.1016/j.cellimm.2016.06.004.
Penitente, A. R., Leite, A. L., de Paula Costa, G., Shrestha, D., Horta, A. L., Natali, A. J. & Talvani, A. (2015) Enalapril in Combination with Benznidazole Reduces Cardiac Inflammation and Creatine Kinases in Mice Chronically Infected with Trypanosoma cruzi. Am J Trop Med Hyg. 93(5):976-82. doi: 10.4269/ajtmh.15-0237.
Rodrigues, M. A., Hueb, M., Nery, A. F. & Fontes, C. J. F. (2007) Possible cardioprotective effect of angiotensin-converting enzyme inhibitors during treatment of American tegumentary leishmaniasis with meglumine antimoniate. Acta Tropica 102 113–118.
Rojas, R., Valderrama, L., Valderrama, M., Varona, M. X., Ouellette, M. & Saravia, N. G. (2006). Resistance to antimony and treatment failure in human Leishmania (Viannia) infection. J Infect Dis. 193, 1375-1383.
Schieffer, B., Bünte, C., Witte, J., Hoeper, K., Böger, R. H., Schwedhelm, E. & Drexler, H. (2004). Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease. J Am Coll Cardiol; 44:362-68.
Schieffer, B., Schieffer, E., Hilfiker-Kleiner, D., Hilfiker, A. Kovanen, P.T., Kaartinen, M. & Drexler, H. (2000) Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation; 101:1372-78.
Sharma, S., Yang, B., Xi, X., Grotta, J. C., Aronowski, J. & Savitz, S. I. (2011). IL-10 directly protects cortical neurons by activating PI-3 kinase and STAT-3 pathways. Brain Res.10;1373:189-94. doi: 10.1016/j.brainres.2010.11.096.
Siegers, C. P., Steffen, B., Robke, A. & Pentz, R. (1999). The effects of garlic preparations against human tumor cell proliferation. Phytomedicine : international journal of phytotherapy and phytopharmacology, v. 6, n. 1, p. 7-11.
World Health Organization. (2014). Leishmaniasis, Fact sheet N°375.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Cristiane Ferreira Lopes de Araújo; Josué Ribeiro da Silva Nunes; Rogério Alexandre Nunes dos Santos; Fabricio Rios-Santos
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
